We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

167 hedge funds and large institutions have $826M invested in Taro Pharmaceutical Industries Ltd. in 2016 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 67 increasing their positions, 47 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 17

43% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 47

9% more funds holding

Funds holding: 153 → 167 (+14)

9% less capital invested

Capital invested by funds: $910M → $826M (-$84M)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

23% less call options, than puts

Call options by funds: $830K | Put options by funds: $1.07M

Holders
167
Holders Change
+14
Holders Change %
+9.15%
% of All Funds
4.45%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.21%
New
34
Increased
67
Reduced
47
Closed
17
Calls
$830K
Puts
$1.07M
Net Calls
-$244K
Net Calls Change
-$1.05M

Top Buyers

1
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$42M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$21.4M
3
MCM
McKinley Capital Management
Alaska
+$14.3M
4
HP
HealthInvest Partners
Sweden
+$13.4M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.85M

Top Sellers

1
ICM
ISZO Capital Management
New York
-$90M
2
TI
Think Investments
California
-$28.8M
3
AIM
Assured Investment Management
New York
-$18.7M
4
KA
Kerrisdale Advisers
Florida
-$7.72M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$7.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
RFC
26
Russell Frank Company
Washington
$6.45M +$803K +5,655 +14%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$6.08M +$2.13M +15,030 +55%
MPM
28
Meritage Portfolio Management
Kansas
$5.79M -$78.8K -555 -1%
Morgan Stanley
29
Morgan Stanley
New York
$5.61M -$52.1K -367 -0.9%
Fidelity Investments
30
Fidelity Investments
Massachusetts
$5.59M +$1.28M +9,000 +30%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$5.56M -$341K -2,400 -6%
Ohio Public Employees Retirement System (OPERS)
32
Ohio Public Employees Retirement System (OPERS)
Ohio
$5.28M +$724K +5,100 +16%
Fiera Capital (Canada)
33
Fiera Capital (Canada)
Quebec, Canada
$4.91M +$4.87M +34,300 New
Korea Investment Corp
34
Korea Investment Corp
South Korea
$4.8M +$1.65M +11,600 +53%
AIIMS
35
Analyst IMS Investment Management Services
Israel
$4.51M -$213K -1,500 -5%
AL
36
AJO LP
Pennsylvania
$4.5M -$2.93M -20,651 -40%
Millennium Management
37
Millennium Management
New York
$4.31M +$4.28M +30,114 New
MCP
38
Moab Capital Partners
New York
$4.3M +$114K +802 +3%
JAM
39
Jupiter Asset Management
United Kingdom
$4.3M – – –
Swiss National Bank
40
Swiss National Bank
Switzerland
$4.28M +$241K +1,700 +6%
BG
41
BlackRock Group
United Kingdom
$4.22M +$1.26M +8,854 +43%
KA
42
Kerrisdale Advisers
Florida
$3.96M -$7.72M -54,381 -66%
AAF
43
Andra AP-fonden
Sweden
$3.6M +$3.57M +25,100 New
HI
44
HBK Investments
Texas
$3.31M +$1.93M +13,602 +143%
CHAM
45
Clear Harbor Asset Management
Connecticut
$3.25M -$82.4K -580 -2%
HHC
46
Hutchin Hill Capital
New York
$3.15M +$412K +2,900 +15%
CCMG
47
Clark Capital Management Group
Pennsylvania
$2.97M +$752K +5,295 +34%
APG Asset Management
48
APG Asset Management
Netherlands
$2.92M +$2.9M +20,400 New
CIBC Asset Management
49
CIBC Asset Management
Ontario, Canada
$2.54M -$105K -742 -4%
Bank of New York Mellon
50
Bank of New York Mellon
New York
$2.51M +$87.9K +619 +4%
1
2
3 4 5

TARO Hedge Fund Activity: Q1 2016 in Review

167 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q1 2016, worth a combined $826M — down 9.2% from $910M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new TARO positions and 17 closed out — a net gain of 17 holders — while 67 added to existing stakes and 47 trimmed.

The largest buyer was Schroder Investment Management Group, adding an estimated $42M. The largest seller was ISZO Capital Management, exiting entirely with an estimated $90M sold.

  • 167 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q1 2016, up from 153 in Q4 2015.
  • Funds reported $826M of Taro Pharmaceutical Industries Ltd. stock for Q1 2016, down 9.2% quarter-over-quarter.
  • 34 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q1 2016 and 17 closed out, a net change of +17 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q1 2016 was Schroder Investment Management Group, an estimated $42M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q1 2016 was ISZO Capital Management, an estimated $90M sold.

Based on aggregated 13F filings for Q1 2016.